CompletedNot Applicable

Percutaneous Aponeurotomy in the Treatment of Dupuytren's Disease

France130 participantsStarted 2015-09

Plain-language summary

The efficiency of percutaneous aponeurotomy in the treatment of Dupuytrens disease is well known. However, the duration of the clinical improvement after aponeurotomy is not well known. This study aims primarily at measuring the incidence rate of local relapse of Dupuytrens-induced finger flessum, within two years following treatment by percutaneous aponeurotomy in Dupuytrens.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patient suffers from Dupuytren disease * Patient has at least one finger with at least 20° flessum on the metacarpophalangeal joint and/or on the proximal interphalangeal joint * Patient has chosen to benefit from local treatment Exclusion Criteria: * Pregnancy * Breastfeeding * No social insurance

What they're measuring

Frequency of local relapse at 24 months

Timeframe: 24 months after treatment by aponeurotomy

Trial details

NCT IDNCT02474576

SponsorGroupe Hospitalier Diaconesses Croix Saint-Simon

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2019-04

View on ClinicalTrials.gov More Dupuytren Disease trials